Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.

about

A novel approach to eliminate detection of contaminating Staphylococcal species introduced during clinical testing Bacterial safety of cell-based therapeutic preparations, focusing on haematopoietic progenitor cells.

P2860

Q36287557-0B729BA9-09AE-4130-816C-56681C5EF7E2 Q38201748-76BB9438-B918-4B7D-BD43-9B1C8A47B68A

P2860

Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.

Item

http://www.wikidata.org/entity/Q43951361

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Microbial contamination of hem ...... ion and regenerative medicine.

@en

Microbial contamination of hem ...... ion and regenerative medicine.

@nl

type

Item

label

Microbial contamination of hem ...... ion and regenerative medicine.

@en

Microbial contamination of hem ...... ion and regenerative medicine.

@nl

prefLabel

Microbial contamination of hem ...... ion and regenerative medicine.

@en

Microbial contamination of hem ...... ion and regenerative medicine.

@nl

P1476

Microbial contamination of hem ...... ion and regenerative medicine.

@en

P2093

Caryn E Good

http://www.w3.org/2001/XMLSchema#string

Katharine P Roman

http://www.w3.org/2001/XMLSchema#string

Michael R Jacobs

http://www.w3.org/2001/XMLSchema#string

Robert M Fox

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.

Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).

What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?

Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.

Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.

Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.

Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets.

Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.

P304

2690-2696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12150

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hillard M Lazarus

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23461309

http://www.w3.org/2001/XMLSchema#string

Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.

about

P2860

P2860

Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698